.

The aim of the paper — is to present the results of the consensus on the terminology used to describe data of high-resolution anorectal manometry.Methods: Online survey was conducted with the help of the public platform “Google forms” with the aim to harmonize the terms, which are used to conduct high-resolution anorectal manometry (HRAM), to agree the conformity of the proposed Russian-language terms to those used in English-language literature, and their abbreviations.Results: According to the aim, 56 specialists of different medical specialties who perform and use the results of HRAM in clinical practice and research were invited to participate in the survey. We received 45 answers from the respondents (42.2% coloproctologists, 22.2% gastroenterologists, 15.6% surgeons, 20% — representatives of other specialties). The response rate was 80.3%. According to the survey, 95.6% of respondents supported the need for harmonization of terms. Ten out of the 11 terms reached consensus level C1 (excellent), 1 term level of consistency was C2 (moderate). 90.9% of respondents (consensus level C1) were in favor of the appropriateness of using common abbreviations. However, the proposed abbreviations of the terms used in the conduct and description of the results of the HRAM can be accepted with reservations (in 10 cases out of 11 consensus level was C2).Conclusions: The agreed in interdisciplinary consensus terms can be approved and recommended for the use in clinical practice and when research data are published in Russian-language scientific literature.

Crohn's disease (CD) is a chronic autoimmune disease of the gastrointestinal tract, which mainly affects young people of productive age. Until now, patients with this disease cannot be cured with by conservative therapy or surgery. The effectiveness of drugs for CD is limited, and their use is often accompanied by adverse events. All this creates a need for new drugs, fundamentally different in the action, with high efficiency and a good safety profile. The review is dedicated to a new biological agent for the treatment of CD blocking interleukins 12 and 23, which are involved in the pathogenesis of inflammation in inflammatory bowel diseases. This review presents the data of phases 2 and 3 clinical trials of the agent and the data obtained in real clinical practice, allowing to conclude about the efficacy and safety, as well as its place in the treatment algorithm for CD.

No abstract

No abstract

Atypical hemolytic uremic syndrome (aHUS) is a rare life-threatening condition caused by uncontrolled complement activation due to mutations in the alternative pathway of complement components. aHUS is characterized by microangiopathic hemolytic anemia, thrombocytopenia, acute renal failure and affecting multiple organ systems. Extra-renal manifestations of aHUS take place in 20% of patients including involvement of the central nervous system, cardiovascular system, lungs, skin and gastrointestinal tract. This case report describes a severe course of atypical hemolytic uremic syndrome in a 21-year-old female, developed ischemic colitis.

The study is based on the analysis of the results of surgical treatment of 298 patients with various diseases of the thyroid gland, who were examined and treated in the department of endocrine surgery of the City Clinical Hospital named after S. P. Botkin from 2012 to 2016. 147 (49.3%) patients of the I group were operated on using extrafascial technique with intersection of the prelaryngeal muscles and visualization of the recurrent laryngeal nerve. 151 (51.7%) patients of group II underwent extrafascial surgical interventions from reduced migratory approaches using modern, including original, methodological approaches. For the prevention of paresis of the larynx in the allocation of recurrent laryngeal nerves, microsurgical instruments and magnifying devices were used. For the prevention of postoperative hypoparathyroidism, in addition to carefully accounting for anatomical and topographic-anatomical features, a «stress-test» and a method of double visual-instrumental recording of the parathyroid gland-induced fluorescence were used. In the first group of patients with surgical treatment, the following complications were recorded: in 2 (1.4%) patients developed permanent, in 8 (5.4%) transient postoperative hypoparathyroidism, and in 3 (2.0%) - temporary unilateral laryngeal paresis. The overall incidence of operative complications was 8.8% (13 patients). In the postoperative period, the following complications were recorded in group II: 2 (1.3%) patients developed transient hypocalcemia, and 1 (0.7%) patient had unilateral laryngeal paresis. The overall incidence of operative complications was 1.99% (3 patients). Analysis of the cosmetic result of the intervention, assessed on the POSAS scale, showed that cosmetic effect was better in group II (p 0.05). Thus, modern surgical interventions in patients with thyroid diseases, including new methodological approaches, have improved the results of surgical treatment with a decrease of the number of complications and achieving a better cosmetic effect of the surgical intervention.

AIM: to reveal risk factors of complications after ileal pouch-anal anastomosis (IPAA) in ulcerative colitis (UC).PATIENTS AND METHODS: from September 2011 by July 2018, 144 patients, who underwent IPAA surgery for UC were included in the study. Univariate and multivariate analyses were performed to reveal the risk factors for complication of IPAA, such as pouchitis, cuffitis, pouch fistulas, anastomotic stricture, pouch leakage, bleeding from IPAA, incontinence and small bowel obstruction (SBO).RESULTS: multivariate regression analysis showed that left-sided UC (OR=12,5, 95% CI 1,7-92, p=0,01), patient's age ≤33 years (OR=5,7, 95% CI 1,54-21,3, p=0,009) and hormone-free period before the IPAA ≤10 months (OR=6,86, 95% CI 1,49-31,56, p=0,01) were associated with cuffitis. The fibrotic changes/wound infection in the anal canal (OR=5,02, 95% CI 1,02-24,69, p=0,04) and albumin <35 g/l (OR=8,11, 95% CI 2,12-30,99, p=0,002) were associated with fistulas. Time between IPAA formation and preventive ileostomy closure >5,6 months was associated with SBO (OR=2,82, 95% CI 1,01-8,31, p=0,0495). Steroid therapy at the time of IPAA surgery was associated with pouch leakage (OR=15,62, 95% CI 2,09116,64, p=0,007). Hand-sewn IPAA (OR=42,54, 95% CI 3,51-516,43, p=0,003) were associated with incontinence. Ulcerative defects in the distal part of the rectum according to transrectal ultrasound were associated with anastomotic stricture (OR=10,46, 95% CI 1,52-71,75, p=0,017). There were no statistically significant risk factors for pouchitis and IPAA bleeding.CONCLUSION: determination of the risk factors for complications of IPAA is a crucial clinical issue for patients with UC. We identified several factors associated with increased risk of complications after pouch formation. Nevertheless, it seems promising to continue the study in order to create the mathematical model that predicts the development of a specific pouch-related complication and determines a group of patients with UC in whom the formation of IPAA is not recommended due to high risk of complications and impaired quality of life.